Jinnie J Rhee

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 8

Top Topics

Atrial Fibrillation

Peritoneal Dialysis

Chronic Kidney Disease

Clinical Practice

Top Venues

Diabetes, obesity & metabolism

This page only lists publications with an associated author ORCID identifier.

Publications

Jinnie J Rhee, Jialin Han, Maria E Montez-Rath, Glenn M Chertow
Comparative effectiveness of sodium-glucose cotransporter-2 inhibitors versus glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes and mild/moderate chronic kidney disease. Diabetes, obesity & metabolism (2024)
Jinnie J Rhee, Jialin Han, Maria E Montez-Rath, Glenn M Chertow
Comparative effectiveness of sodium-glucose cotransporter-2 inhibitors versus glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes and mild/moderate chronic kidney disease. Diabetes, obesity & metabolism 26 (4) (2024)
Jinnie J Rhee, Jialin Han, Maria E Montez-Rath, Glenn M Chertow
Comparative effectiveness of sodium-glucose cotransporter-2 inhibitors versus glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes and mild/moderate chronic kidney disease. Diabetes, obesity & metabolism 26 (4) (2024)
Jinnie J Rhee, Jialin Han, Maria E Montez-Rath, Glenn M Chertow
Comparative effectiveness of sodium-glucose cotransporter-2 inhibitors versus glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes and mild/moderate chronic kidney disease. Diabetes, obesity & metabolism 26 (4) (2024)
Jinnie J Rhee, Jialin Han, Maria E Montez-Rath, Glenn M Chertow
Comparative effectiveness of sodium-glucose cotransporter-2 inhibitors versus glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes and mild/moderate chronic kidney disease. Diabetes, obesity & metabolism 26 (4) (2024)
Jinnie J Rhee, Jialin Han, Maria E Montez-Rath, Glenn M Chertow
Comparative effectiveness of sodium-glucose cotransporter-2 inhibitors versus glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes and mild/moderate chronic kidney disease. Diabetes, obesity & metabolism 26 (4) (2024)
Jinnie J Rhee, Jialin Han, Maria E Montez-Rath, Sun H Kim, Mark R Cullen, Randall S Stafford, Wolfgang C Winkelmayer, Glenn M Chertow
Cardiovascular outcomes associated with prescription of sodium-glucose co-transporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors in patients with diabetes and chronic kidney disease. Diabetes, obesity & metabolism 24 (5) (2022)
Jinnie J Rhee, Meg J Jardine, Glenn M Chertow, Kenneth W Mahaffey
Dedicated kidney disease-focused outcome trials with sodium-glucose cotransporter-2 inhibitors: Lessons from CREDENCE and expectations from DAPA-HF, DAPA-CKD, and EMPA-KIDNEY. Diabetes, obesity & metabolism (2021)